SweeGen adds Bestevia Reb N to its portfolio of stevia sweeteners.
Photo © iStockphoto.com/ olm26250
SweeGen (Rancho Santa Margarita, CA) has successfully scaled up production of Bestevia Rebaudioside N (Reb N) to begin commercialization. The ingredient’s unique sensory profile makes it particularly attractive for beverage applications.
“Bestevia Reb N has a unique sweet profile that helps us create solutions that have a taste profile closer to both full-calorie and high intensity sweeteners,” said Shari Mahon, senior vice president of global application technology, in a press release. “Our solutions are one of the most unique and tailored in the industry because of our access to the widest range of Rebs for sugar reduction.”
SweeGen’s Bestevia Reb N is produced using a patented bioconversion technology developed by Conagen, a biotech innovator of sustainable ingredients. “The introduction of Reb N is another great example of how Conagen’s deep expertise in bioconversion technology enables the creation of unique stevia sweeteners,” said Conagen’s vice president of innovation, Casey Lippmeier, PhD. “With such a wide range of next generation stevia offerings now available, we will see a new level of innovation in better-for-you products that was previously considered impossible.”
Brightseed launches clinically validated ingredient, Bio Gut Core, to support gut barrier function
May 21st 2025The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.
A country-by-country blueprint for nutraceutical success in Europe
May 20th 2025The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.